Mounjaro 5 mg is prescribed by an endocrinologist for patients with the following goals: 🔹 Type 2 Diabetes Mellitus: Long-term treatment to maintain target glucose and glycated hemoglobin (HbA1c) levels. 🔹 Obesity Treatment: Weight reduction and management in adult patients with a BMI ≥30 kg/m² or ≥27 kg/m² in the presence of accompanying risk factors (diabetes, hypertension, apnea).

Dosage and administration

Sales Form: 1 multi-dose KwikPen (2.4 ml of solution) containing 4 doses of 5 mg.⚠️ INSTRUCTIONS FOR USE: Dosage Regimen: The drug is administered once a week. The 5 mg dosage is often a maintenance or intermediate step when titrating doses up to 7.5 mg, 10 mg, or 15 mg. Method of Administration: Subcutaneous injection into the abdomen, front of the thigh, or upper arm. It is recommended to rotate the injection site each week. Timing: On any day of the week at any time, regardless of food. It is advisable to choose a fixed day of the week. Storage: Store the unused pen in the refrigerator (2°C–8°C). Do not freeze! After the first injection, the pen can be stored at room temperature (up to 30°C) for up to 21 days.

⛔ Hereditary Risks: Personal or family history of medullary thyroid carcinoma. ⛔ Endocrine Disorders: Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). ⛔ Pregnancy and Breastfeeding: Use is not recommended. Women of childbearing age should use reliable methods of contraception. ⛔ Type of Diabetes: Not used for type 1 diabetes mellitus. Serious kidney or gastrointestinal diseases (severe gastroparesis).

Side effects are often temporary and appear during the period of adaptation to the 5 mg dosage: 🤢 Digestive System (frequent): Nausea, diarrhea, vomiting, dyspepsia, epigastric pain, constipation. 🍽️ Appetite: Pronounced reduction in hunger, leading to rapid satiety. 🏃♂️ General: Feeling of fatigue, weakness, dizziness. 💉 Injection Site Reactions: Itching or slight redness of the skin. ⚠️ Serious Warnings: Risk of pancreatitis, dehydration due to vomiting (it is important to maintain hydration), potential gallbladder problems.

Mounjaro KwikPen 5 — Tirzepatide 5 mg, 1 pcs, Eli Lilly

100% original product

Active ingredient

Tirzepatide

Manufacturer

Eli Lilly

Dosage 5 mg

Dosage form Prefilled pen

Pens per pack 1

Mounjaro KwikPen 5 — Tirzepatide 5 mg (1 Pen / 4 Doses)

Name: Mounjaro KwikPen 5
Brand: Eli Lilly
SKU: PROD-268
Price: 18190 UAH
Availability: InStock

18190₴ ~~19521₴~~ -7%

Mounjaro KwikPen 5 mg (Tirzepatide) is an innovative injectable medication for the treatment of type 2 diabetes and effective weight reduction. Tirzepatide is the world's first dual agonist of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. By simultaneously acting on two types of hormones, Mounjaro provides superior blood sugar control and promotes significant weight loss compared to previous generation drugs.

Manufacturer: Eli Lilly. The KwikPen format is a convenient multi-dose pre-filled pen designed to ensure dosing precision and ease of administration. The 5 mg dosage is typically the next step after the initial adaptation phase (2.5 mg) and allows for a more pronounced therapeutic effect.

Key Features:

✅ Dual Action: The synergy of GIP and GLP-1 receptors not only normalizes insulin but also effectively suppresses hunger at the level of the central nervous system.
✅ KwikPen Convenience: One pen contains 4 doses of 5 mg each, designed for a full month of therapy (one injection per week).
✅ Metabolic Control: The drug helps reduce body fat, improves lipid profiles, and lowers the burden on the cardiovascular system.

Mounjaro 5 mg is prescribed by an endocrinologist for patients with the following goals:

🔹 Type 2 Diabetes Mellitus: Long-term treatment to maintain target glucose and glycated hemoglobin (HbA1c) levels.
🔹 Obesity Treatment: Weight reduction and management in adult patients with a BMI ≥30 kg/m² or ≥27 kg/m² in the presence of accompanying risk factors (diabetes, hypertension, apnea).

Sales Form: 1 multi-dose KwikPen (2.4 ml of solution) containing 4 doses of 5 mg.

⚠️ INSTRUCTIONS FOR USE:

Dosage Regimen: The drug is administered once a week. The 5 mg dosage is often a maintenance or intermediate step when titrating doses up to 7.5 mg, 10 mg, or 15 mg.
Method of Administration: Subcutaneous injection into the abdomen, front of the thigh, or upper arm. It is recommended to rotate the injection site each week.
Timing: On any day of the week at any time, regardless of food. It is advisable to choose a fixed day of the week.
Storage: Store the unused pen in the refrigerator (2°C–8°C). Do not freeze! After the first injection, the pen can be stored at room temperature (up to 30°C) for up to 21 days.

⛔ Hereditary Risks: Personal or family history of medullary thyroid carcinoma.
⛔ Endocrine Disorders: Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
⛔ Pregnancy and Breastfeeding: Use is not recommended. Women of childbearing age should use reliable methods of contraception.
⛔ Type of Diabetes: Not used for type 1 diabetes mellitus.
Serious kidney or gastrointestinal diseases (severe gastroparesis).

Side effects are often temporary and appear during the period of adaptation to the 5 mg dosage:

🤢 Digestive System (frequent): Nausea, diarrhea, vomiting, dyspepsia, epigastric pain, constipation.
🍽️ Appetite: Pronounced reduction in hunger, leading to rapid satiety.
🏃‍♂️ General: Feeling of fatigue, weakness, dizziness.
💉 Injection Site Reactions: Itching or slight redness of the skin.
⚠️ Serious Warnings: Risk of pancreatitis, dehydration due to vomiting (it is important to maintain hydration), potential gallbladder problems.

Notice. The information on this page is for reference only and does not replace medical consultation. Always consult a healthcare professional and read the manufacturer's instructions before using any medicine. Self-medication may be dangerous. Information updated: 20.04.2026